Western blot (WB) and immunofluorescence experiments revealed that MFAP5 plays a crucial role in the progression of CAVD in the context of diabetes, offering new insights into the disease mechanism. The gene discussed is MFAP5; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.